NCT02640326

Brief Summary

It is common practice to insert a Foley catheter into the bladder to drain urine during and after a lung resection. Recently, there has been increasing interest in the potential risks associated with this catheterization, particularly with regard to infection. As thoracic surgery adopts minimally invasive surgical techniques, the need for urinary catheterization during surgery is being questioned since these less invasive surgeries are known to result in less post-operative acute pain, shorter length of stay, and other outcomes that tend to decrease overall anesthetic needs for this patient population. Thus, there is a need to investigate whether patients who have had a minimally invasive lung resection truly need the Foley catheter at all. This will be achieved by assigning patients to either an experimental no-catheter group or the standard of care routine urinary catheter group to determine if patients with no catheter experience different rates of complications. This pilot study will primarily determine if there is a difference in post operative urinary complications between the groups. It is hoped that this study will definitively determine whether a Foley urine catheter is a necessary procedure in the course of a minimally invasive lung resection.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 28, 2015

Completed
2.9 years until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

December 21, 2018

Status Verified

December 1, 2018

Enrollment Period

Same day

First QC Date

December 22, 2015

Last Update Submit

December 19, 2018

Conditions

Keywords

Urinary CatheterizationRandomized Controlled TrialThoracic Surgery, Video-AssistedQuality ImprovementEvidence-Based PracticePost-operative complications

Outcome Measures

Primary Outcomes (1)

  • Postoperative urinary complications

    Compating the difference in the rate of the occurrence of one or more of postoperative urinary tract infection, postoperative urinary retention requiring 1 catheterization, and postoperative urinary retention requiring more than 1 catheterization between the catheterized and the non-catheterized arms

    From the time of surgery to post-operative Day 14.

Secondary Outcomes (6)

  • Length of Hospital Stay

    During patient hospital stay (Estimated to be between post-operative day 0 and day 7)

  • Rate of Post-operative Hypotension

    During patient hospital stay (Estimated to be between post-operative day 0 and day 7)

  • Total IV fluid administration

    First 48 hours of the perioperative period

  • Validity of the bladder scanner tool relative to actual urine output

    During patient hospital stay (Estimated to be between post-operative day 0 and day 7)

  • Rate of peri-operative pulmonary complications

    During patient hospital stay (Estimated to be between post-operative day 0 and day 7)

  • +1 more secondary outcomes

Study Arms (2)

Active Comparator

ACTIVE COMPARATOR

The catheterized arm will have Standard of care Foley urinary catheter insertion according to usual institutional care pathways in the operating room prior to surgery initiation. The urinary catheter will be assessed for removal on the morning of post-operative day 1, and patients will be monitored for urinary complications once catheter is removed until patient has successfully voided spontaneously within 8 +/- 2 hours.

Other: No Foley Urinary Catheter

Experimental Arm

EXPERIMENTAL

The non-catheterized arm will have standard of care Foley urinary catheter insertion, with no Foley Urinary Catheter inserted prior to, during, or after surgery unless the patient is showing signs of urinary retention after surgery. Patient will be monitored for urinary complications starting in the recovery room until patient has successfully voided spontaneously within 8 +/- 2 hours

Other: Standard of care Foley urinary catheter insertion

Interventions

No Foley urinary catheter will be put in place during the operation

Also known as: Experimental Comparator
Active Comparator

A Foley urinary catheter will be put in place during the operation

Also known as: Active Comparator
Experimental Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must undergo minimally invasive Video-Assisted Thoracoscopic Thoracic Surgery (VATS) or Robotic-Assisted Thoracoscopic Thoracic Surgery (RTS) anatomic pulmonary resection surgery (lobectomy, segmentectomy)
  • Must be diagnosed with primary or secondary lung cancer eligible for resection

You may not qualify if:

  • Patients who are unwilling to comply with study procedures
  • Patients who are unable to complete questionnaires with assistance
  • Non-VATS/RTS pulmonary resection patients
  • Non-anatomic pulmonary resection
  • Patients with benign disease
  • Patients requiring chronic urinary catheterization
  • Patients with contraindications to placement of urinary catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Healthcare Hamilton

Hamilton, Ontario, L8N 4A6, Canada

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell LungLung NeoplasmsUrinary RetentionUrinary Tract Infections

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesInfections

Study Officials

  • John Agzarian, MD, MPH, FRCSC

    McMaster University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2015

First Posted

December 28, 2015

Study Start

December 1, 2018

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

December 21, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations